Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Dupilumab can both trigger and treat alopecia areata, often leading to hair regrowth.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Certain IL-18 gene variations may increase the risk of alopecia areata.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Abnormal ECM and immune cell interactions can cause skin diseases.

NK cells play a role in skin diseases like eczema and psoriasis.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Vitamin A affects hair loss and immune response in alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

The skin's immune system helps it regenerate and fight infections.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.